ArticleJournal of nanobiotechnology2025
A new NCL-targeting aptamer-drug conjugate as a promising therapy against esophageal cancer.
Xue Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it